Takeda taps Selecta for $1.1B gene therapy research pact

After a tough pre-pandemic rout that saw it slash staff, steer around a cash crunch and face a bitter setback in the clinic, Selecta Biosciences is bouncing back with a major new biobucks pact with Japan’s Takeda.